Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates
Biorestorative Therapies, Inc. (BRTX) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to a loss of…